[1]白雪莹.Lp-PLA2与冠心病冠状动脉病变程度的相关性分析[J].医学信息,2020,33(20):162-163.[doi:10.3969/j.issn.1006-1959.2020.20.051]
　BAI Xue-ying.Correlation Between Lp-PLA2 and the Severity of Coronary Artery Disease in Coronary Heart Disease[J].Medical Information,2020,33(20):162-163.[doi:10.3969/j.issn.1006-1959.2020.20.051]
点击复制

Lp-PLA2与冠心病冠状动脉病变程度的相关性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年20期
页码:
162-163
栏目:
诊疗技术
出版日期:
2020-10-15

文章信息/Info

Title:
Correlation Between Lp-PLA2 and the Severity of Coronary Artery Disease in Coronary Heart Disease
文章编号:
1006-1959（2020）20-0162-02
作者:
白雪莹
（天津市河西医院检验科，天津 300202）
Author(s):
BAI Xue-ying
(Department of Laboratory Medicine,Tianjin Hexi Hospital,Tianjin 300202,China)
关键词:
冠心病; 血浆脂蛋白相关磷脂酶A2; 冠状动脉; 病变程度; 冠脉Gensini积分
Keywords:
Coronary heart disease; Plasma lipoprotein-related phospholipase A2; Coronary artery; Disease degree; Coronary Gensini score
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2020.20.051
文献标志码:
A
摘要:
目的 探讨血浆脂蛋白相关磷脂酶A2（Lp-PLA2）水平与冠心病冠状动脉病变程度的相关性。方法 选取2019年9~12月我院接受治疗的100例冠心病患者作为冠心病组，根据冠状动脉病变程度分为轻微病变、轻中度病变、中度病变、中重度病变、重度病变、极重度病变，另选取31例同期在我院健康体检者31名作为健康对照组，比较冠心病组不同冠状动脉病变程度患者冠脉Gensini积分，冠心病组与健康对照组Lp-PLA2水平，并分析其与冠心病冠状动脉病变程度的相关性。结果 冠心病组中冠状动脉轻微病变者23例，轻中度病变者21例，中度病变者17例，中重度病变者19例，重度病变者11例，极重度病变者9例；其中轻微病变者冠脉Gensini积分低于轻中度病变者、中度病变者、中重度病变者、重度病变者、极重度病变者（P＜0.05）；极重度病变者Lp-PLA2水平最高，重度病变者、中重度病变者、中度病变者、轻中度病变者、轻微病变者、健康对照组次之，组间比较，差异有统计学意义（P＜0.05）；Pearson相关性分析显示，Lp-PLA2水平与冠脉Gensini积分呈正相关（r=0.841，P＜0.05）。结论Lp-PLA2与冠心病冠状动脉病变程度存在一定相关性，临床可通过检测Lp-PLA2评估冠心病患者冠状动脉的狭窄程度。
Abstract:
Objective To investigate the correlation between the level of plasma lipoprotein-related phospholipase A2 (Lp-PLA2) and the severity of coronary artery disease in coronary heart disease.Methods 100 patients with coronary heart disease who received treatment in our hospital from September to December 2019 were selected as the coronary heart disease group.According to the degree of coronary artery disease, it was divided into mild disease, mild to moderate disease, moderate disease, moderate to severe disease, severe disease, and extremely severe disease. Another 31 cases were selected during the same period in our hospital who received routine health examination and proved to be healthy. Volunteers as a healthy control group compared the coronary Gensini scores of patients with different coronary artery lesions in the coronary heart disease group, the Lp-PLA2 levels in the coronary heart disease group and the healthy control group, and analyzed its correlation with the coronary artery lesions of coronary heart disease.Results In the coronary heart disease group, there were 23 cases of mild coronary artery disease, 21 cases of mild to moderate disease, 17 cases of moderate disease, 19 cases of moderate to severe disease, 11 cases of severe disease, and 9 cases of extremely severe disease; among them, there were mild disease. The coronary Gensini scores were lower than those with mild to moderate lesions, moderate lesions, moderate to severe lesions, severe lesions, and extremely severe lesions(P<0.05); Lp-PLA2 for extremely severe lesions level was the highest, followed by patients with severe disease, moderate to severe disease, moderate disease, mild to moderate disease, mild disease, and healthy control group(P<0.05); Pearson correlation Sexual analysis showed that the level of Lp-PLA2 was positively correlated with the coronary Gensini score (r=0.841,P＜0.05).Conclusion There was a certain correlation between the level of Lp-PLA2 and the degree of coronary artery disease in coronary heart disease. Clinically, the level of Lp-PLA2 could be used to assess the degree of coronary artery stenosis in patients with coronary heart disease.

参考文献/References:

[1]刘长召,王玲,陈文江.血浆脂蛋白相关磷脂酶A2水平与急性心肌梗死相关性的临床研究[J].临床内科杂志,2016,33(11):744-746. [2]中华医学会心血管病学分会介入心脏病学,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J].中华心血管病杂志,2018,46(9):680-694. [3]丁伟,王邦宁.非高密度脂蛋白胆固醇水平与冠心病患者冠状动脉病变Gensini评分的相关性研究[J].安徽医学,2016,37(2):167-170. [4]刘静,张铁亮,戴远辉,等.冠心病患者血清妊娠相关血浆蛋白A与胰岛素样生长因子I的表达及两者联合检测的临床意义研究[J].中国循证心血管医学杂志,2019,11(2):223-226. [5]陆文林,严士荣,赵领会,等.血浆脂蛋白相关磷脂酶A2及非高密度脂蛋白胆固醇水平与冠状动脉病变程度关系的初步研究[J].中国医师杂志,2016,18(12):1875-1877. [6]刘艳丽,李婷婷,王艳,等.血浆脂蛋白相关磷脂酶A2水平对慢性心力衰竭患者预后的影响[J].现代中西医结合杂志,2015,24(4):425-428.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(20):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(20):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(20):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(20):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(20):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(20):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(20):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(20):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(20):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(20):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]

更新日期/Last Update: 1900-01-01